Neuroprotective implications of L-carnitine include: -Reduction of neuronal atrophy in hippocampus and amygdala -Elimination of oxidative metabolites toxic to neurons -Protection against hypoxic injury to neurons -Promoting the function of peripheral nerves and upregulates conduction velocity In one study, supplementation with 1000 mg/day of L-Carnitine took only two weeks to achieve remission in mood disturbances and neuropathic pain
Further exploration of GLP-1s molecular mechanisms in PD could provide new preventive and therapeutic approaches, especially for PD patients with concurrent T2DM
People being considered for metabolic surgery should be evaluated for comorbid psychological conditions and social and situational circumstances that may interfere with surgery outcomes
Mochi is primarily self-pay for compounded medications, but can send brand-name prescriptions to local pharmacies for patients using insurance
others do better on tirzepatide
Rybelsus, the GLP-1 agonist in Pill Form, to Launch in Canadian Market in April 2020 By Frida Velcani Rybelsus, a GLP-1 agonist pill already approved in Europe and the US, has just been approved by Health Canada for adults with type 2 diabetes In Canada, the first and only GLP-1 agonist pill has received approval for people with type 2 diabetes